Cignpost Diagnostics
William Glynn is a dedicated scientist currently working at Cignpost Diagnostics Ltd. since February 2021, specializing in RT-PCR testing for COVID-19 among airport passengers and film crews. Prior experience includes serving as an undergraduate at the University of Birmingham from September 2016 to November 2020, and as a research student at the Institute of Cancer and Genomic Sciences, where research focused on the connection between RNA polymerase II mutations and cancer morbidity. William also participated in a Year in Industry at Earlham Institute, and completed a summer internship at the Wellcome Trust Centre for Human Genetics, where gene expression during sepsis was assessed. A prior internship at the Mullard Space Science Laboratory involved developing a project proposal for a telescope array with a focus on extra-solar planets. William Glynn holds a Master's degree in Biology/Biological Sciences from the University of Birmingham.
This person is not in any teams
Cignpost Diagnostics
Cignpost Diagnostics, LTD. is a leading health and diagnostics company, operating globally to empower and guide people towards living a healthier life. By combining scientific expertise with a relentless focus on people, Cignpost has quickly evolved to become a global leader in COVID-19 screening and health diagnostics, establishing safe, managed environments across a range of sectors, including elite sports, defence, film and TV production, and financial services. Following success with clients including Netflix, the BBC and the PGA European Tour, today services extend beyond testing, providing strategic consultancy on business continuity and customised end-to-end solutions to meet client needs. Through a network of regional health care centres, Cignpost ExpressTest is the UK’s leading and largest COVID test provider for consumers, particularly in the travel sector, with testing centres across the country including at Heathrow, Gatwick, Edinburgh, Birmingham Airport, Reading and Brent Cross.